Clinical trial to examine the efficacy and safety of brexpiprazole in patients with borderline personality disorder.
-
February 23, 2010
The Olin Neuropsychiatry Research Center at the Institute of Living at Hartford Hospital is conducting a study with healthy controls. Qualifying participants will be asked to come in for 1 day to participate in a brain imaging (MRI) and additional testing research project. The study is open to adults aged 18-60.
-
June 24, 2013
Researchers at the Memory Care Center want to learn more about factors that increase risk for developing Alzheimer's disease and related forms of dementia. We are looking for research volunteers who are 45-65 years old and who have had a parent diagnosed with Alzheimer's disease or a related form of dementia.
-
January 04, 2017
This clinical research study is being conducted to evaluate an investigational medication for treatment-resistant depression. We are currently enrolling patients for a clinical research study to look at the effectiveness and dosing requirements of an investigational medication that may help with the symptoms of depression.
-
January 04, 2017
Does your child have depression? If so, s/he may be eligible to participate in a new research study being conducted by Dr. Salma Malik testing the effects of Vilazodone for the treatment of Depression. Participants must be 7 to 17 years of age and generally healthy.
-
January 04, 2017
The Burlingame Research Center at The Institute of Living is conducting a study on patients ages 18-64 that are currently taking an anti-depressant and responding to this therapy. This study will last up to 12 months and financial compensation for time and travel may be provided.
-
January 06, 2017
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a 4-week, double-blind, clinical trial using Ziprasidone treatment study in pediatric and adolescent mania associated with Bipolar I Disorder.
-
January 06, 2017
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment study in pediatric and adolescent depression associated with Bipolar I Disorder.
-
January 06, 2017
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a 12 month observational study for patients currently being treated with an approved antidepressant treatment.
-
January 06, 2017
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 12-16 years of age for a 6-week, double-blind, clinical trial with, NaBen, as an add-on treatment study in pediatric and adolescent Schizophrenia.